Literature DB >> 28748088

Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population.

Rajiv Sonti1, Megan E Conroy1, Elena M Welt1, Yi Hu2, George Luta2, Daniel B Jamieson1.   

Abstract

PURPOSE: To create a model predictive of an individual's risk of developing a de novo multidrug-resistant (MDR) infection while in the intensive care unit (ICU).
METHODS: This is a case-control study in which 189 ICU patients diagnosed with their first infection with an MDR organism were compared on the basis of demographic, past medical and clinical variables to randomly selected ICU patients without such an infection, era-matched in a 2:1 ratio. A prediction tool was derived using multivariate logistic regression.
RESULTS: Five features remained predictive of developing an infection with a drug-resistant pathogen: hospitalization within a year [adjusted odds ratio (OR) 2.14], chronic hemodialysis (3.86), underlying oxygen-dependent pulmonary disease (1.86), endotracheal intubation within 24 h (2.46) and reason for ICU admission (respiratory failure 2.89, non-respiratory failure, non-shock presentation 1.85). Using a scoring system (0-7 points) based on the adjusted OR, risk categories were derived (low: 0-2 points, intermediate: 3-4 points and high risk: 5-7 points). The negative predictive value at a score cutoff of 2 is excellent (88.9%).
CONCLUSIONS: A clinical prediction rule comprised of five easily measured ICU variables reasonably discriminates between patients who will develop their first MDR infection versus those who will not.

Entities:  

Keywords:  ICU; MRSA; antimicrobial stewardship; logistic model; multidrug-resistant infection; sepsis

Year:  2017        PMID: 28748088      PMCID: PMC5507394          DOI: 10.1177/2049936117715403

Source DB:  PubMed          Journal:  Ther Adv Infect Dis        ISSN: 2049-9361


  52 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 2.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012.

Authors:  Helio S Sader; David J Farrell; Robert K Flamm; Ronald N Jones
Journal:  Int J Antimicrob Agents       Date:  2014-02-07       Impact factor: 5.283

4.  Genotypic and phenotypic characterization of methicillin-susceptible Staphylococcus aureus isolates misidentified as methicillin-resistant Staphylococcus aureus by the BD GeneOhm MRSA assay.

Authors:  Paul D Stamper; Lisa Louie; Henry Wong; Andrew E Simor; Jason E Farley; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

5.  The role of systemic antibiotics in acquiring respiratory tract colonization with gram-negative bacteria in intensive care patients: a nested cohort study.

Authors:  Irene P Jongerden; Ben Speelberg; Claudia L Satizábal; Anton G Buiting; Maurine A Leverstein-van Hall; Jozef Kesecioglu; Marc J Bonten
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

6.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

Review 7.  Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.

Authors:  François Barbier; Antoine Andremont; Michel Wolff; Lila Bouadma
Journal:  Curr Opin Pulm Med       Date:  2013-05       Impact factor: 3.155

8.  Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.

Authors:  Chris M Parker; Jim Kutsogiannis; John Muscedere; Deborah Cook; Peter Dodek; Andrew G Day; Daren K Heyland
Journal:  J Crit Care       Date:  2008-03       Impact factor: 3.425

9.  Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.

Authors:  Marya D Zilberberg; Andrew F Shorr; Scott T Micek; Cristina Vazquez-Guillamet; Marin H Kollef
Journal:  Crit Care       Date:  2014-11-21       Impact factor: 9.097

10.  Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study.

Authors:  Ching Jou Lim; Allen C Cheng; David C M Kong; Anton Y Peleg
Journal:  BMC Infect Dis       Date:  2014-03-04       Impact factor: 3.090

View more
  2 in total

1.  Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE.

Authors:  Laura Teysseyre; Cyril Ferdynus; Guillaume Miltgen; Thomas Lair; Thomas Aujoulat; Nathalie Lugagne; Nicolas Allou; Jérôme Allyn
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-20       Impact factor: 4.887

2.  A Study of Multidrug-Resistant, Colistin-Only-Sensitive Infections in Intubated and Mechanically Ventilated Patients Over 2 Years.

Authors:  Ipe Jacob; Pradeep Rangappa; Lakshman C Thimmegowda; Karthik Rao
Journal:  J Glob Infect Dis       Date:  2020-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.